MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
53.94
-0.27
-0.50%
After Hours: 54.10 +0.16 +0.30% 19:56 12/31 EST
OPEN
54.21
PREV CLOSE
54.21
HIGH
54.35
LOW
53.91
VOLUME
7.87M
TURNOVER
--
52 WEEK HIGH
61.00
52 WEEK LOW
42.38
MARKET CAP
109.81B
P/E (TTM)
18.21
1D
5D
1M
3M
1Y
5Y
1D
2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky
Barchart · 1d ago
Looking Into Bristol-Myers Squibb Co's Recent Short Interest
Benzinga · 12/31/2025 20:00
Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months
NASDAQ · 12/31/2025 19:42
Notable ETF Outflow Detected - SCHD, BMY, LMT, MO
NASDAQ · 12/31/2025 17:31
2 Dividend Stocks to Scoop Up Without Hesitation Right Now
The Motley Fool · 12/31/2025 17:05
Ex-Dividend Reminder: Encompass Health, Bristol Myers Squibb and Federal Realty Investment Trust
NASDAQ · 12/31/2025 15:02
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Seeking Alpha · 12/31/2025 13:22
Can BMY's Growth Portfolio Drive Top-Line Expansion in 2026?
NASDAQ · 12/31/2025 12:32
More
About BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.